COVID-19 Toolkit

NOTE:  Created on April 3, 2020, this resource has been added to the toolkit menu for retrospective access if needed.

The situation surrounding the COVID-19 pandemic will continue to change and evolve; what will not change is our Society’s commitment to do everything we can to support our members. ISOPP is therefore committed to collecting and sharing COVID-19 and Cancer Care resources.

We are delighted to share resources which provide COVID-19 guidance from various regulators to knowledge support to pharmacists and patients for cancer care during this pandemic. Through our resources, we provide further support to our membership with some of the most interesting research findings and virtual interactions with experts related to the impact of COVID-19 on cancer care globally.

We have divided these resources into 5 categories.

Date resource created: April 3, 2020

Resources

  1. COVID-19 resources from National Comprehensive Cancer Network: Offers recommendations on the provision of cancer care for a range of different cancer sites and supportive care areas.
     
  2. American Society of Clinical Oncology (ASCO) Coronavirus Resources: Covers a wide range of topics, including modifications to patient care, service provision, resource allocation and occupational safety during the COVID-19 pandemic in an FAQ format.
     
  3. Emergency Resources: COVID-19 from Society of Critical Care Medicine: Comprises a rapid resource centre with FAQs relevant to the provision of patient care and services in critical care.
     
  4. Resources from American Society of Health-System Pharmacists: Provides a summary table on evidence related to COVID-19 treatments and updates on the current status of pharmacy supplies in the United States.
     
  5. Pharmacists’ guide to Corona Virus, American Pharmacist Association: Provides a summary page of practical information that pharmacists should know during the COVID-19 pandemic. Also contains links to CDC guidance documents and PubMed search results for the latest COVID-19 literature.
     
  6. National Institute for Health and Care Excellence (NICE): Summarizes rapid guidelines and evidence summaries on COVID-19 treatments and patient care (including cancer patients) during the pandemic.
     
  7. Clinical evidences summaries from Ministry of Health, Singapore: Consists of clinical evidence summaries by the Ministry of Health, Singapore on potential COVID-19 treatments.
     
  8. COVID-19 resources from CADTH: Offers a comprehensive COVID-19 evidence bundle that provides evidence summaries on COVID-19 prevention, infection control, screening/testing and treatment.
     

Would you like to share more resources on COVID-19 with ISOPP members? Send your resources to the Education Committee Chair at education@isopp.org.